Clinical Trial: Hematological and Coagulation Markers in Predicting Placenta Accreta Spectrum in Placenta Previa

U.S., Sept. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07826247) titled 'Hematological and Coagulation Markers in Predicting Placenta Accreta Spectrum in Placenta Previa' on Sept. 13.

Brief Summary: Placenta accreta spectrum (PAS) is a serious pregnancy complication where the placenta attaches too deeply into the wall of the uterus. This condition can lead to severe complications during delivery, including heavy bleeding, the need for blood transfusions, intensive care unit (ICU) admission, or the surgical removal of the uterus (hysterectomy).

Currently, doctors primarily use ultrasound to detect PAS before birth, but the accuracy of ultrasound can vary depending on the equipment and the doctor's exper...